Miss Sayul Kang
Busan (Korea (Republic of))
Stroke rate after twelve versus 30 month dual antiplatelet therapy in percutaneous coronary intervention patients using korean national health insurance service (nhis)
Event: ESC Congress 2017
Topic: Drug therapy
Session: Remaining in the spotlight: antiplatelet agents
ESC 365 is supported by
